Neocis receives FDA clearance for Yomi component

May 12, 2020

The component reduces CT scanner field-of-view requirements, which broadens the target market for adopting robot-assisted dental surgery.

Dental robotics company Neocis, Inc. has received a 510(k) clearance from the U.S. Food and Drug Administration for a new component, the company announced today in a press release.

This component was cleared for use in Yomi®, the first and only FDA cleared robot-assisted dental surgery system. The component reduces CT scanner field-of-view (FOV) requirements, which broadens the target market for adopting robot-assisted dental surgery, the press release read.

Yomi provides robot-assisted guidance relative to a pre-operative plan based on a CT scan. Many dental offices have in-office cone beam CT scanners, which provide a true 3D visualization of the patient as compared to a 2D X-ray or projected panoramic scan. The Yomi system is compatible with all DICOM format CT scans, which includes most scanners on the market, Neocis said in the statement. CT scanners vary in the FOV they offer. With this FDA clearance, Yomi will be compatible with a wider variety of scanners across a larger range of FOV.

"Increasing the compatibility of Yomi enables us to reach a wider market of implant surgeons,” said Alon Mozes, Ph.D., CEO of Neocis. “As we continue to improve the technology and the workflow, we’re excited to get this into the hands of more dental implant surgeons so they can benefit from the use of robot-assisted technology.”

Neocis, Inc. is a private company located in Miami, Fla. that manufactures and markets the Yomi system and aims to transform dental surgery with advanced robotics. For more information, visit neocis.com.